Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY

(HZNP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
01/25Horizon Therapeutics plc Announces First Patient Enrolled in Phase 2b Pivotal Trial Eva..
AQ
01/24Horizon Therapeutics plc Announces First Patient Enrolled in Phase 2b Pivotal Trial Eva..
BU
01/11Horizon Therapeutics plc Submits Supplemental Biologics License for the Concomitant Use..
AQ
01/10Horizon Therapeutics plc Submits Supplemental Biologics License for the Concomitant Use..
BU
01/062022 Could be a Banner Year for Biotech Stocks as per top managers (SPRC, HOTH, NLSP, P..
AQ
01/06Horizon Therapeutics plc Announces Significant Expansion of East Coast Research and Dev..
BU
2021Horizon Therapeutics plc to Participate in Upcoming Investor Conferences
BU
2021HORIZON THERAPEUTICS PUBLIC LTD CO : Regulation FD Disclosure (form 8-K)
AQ
2021Alpine Immune Sciences and Horizon Therapeutics plc Announce Exclusive License and Coll..
BU
2021Horizon Therapeutics plc Makes $100,000 Seed Donation to Support Fundraising Efforts to..
AQ
2021Horizon Therapeutics plc Makes $100,000 Seed Donation to Support Fundraising Efforts to..
BU
2021Great Place to Work Names Horizon Therapeutics plc to Best Workplaces for Parents List
BU
2021Horizon Therapeutics plc Provides Academic Scholarships to Help Economically Disadvanta..
BU
2021New Analysis Published in Multiple Sclerosis and Related Disorders Supports the Efficac..
BU
2021Horizon Therapeutics plc Receives CHMP Positive Opinion for UPLIZNA (inebilizumab) as a..
AQ
2021Horizon Therapeutics plc - New Real-World Data Show High Rate of Patient Adherence to T..
AQ
2021Horizon Therapeutics Recognizes Second Annual Thyroid Eye Disease (TED) Awareness Week ..
BU
2021New Real-World Data Show High Rate of Patient Adherence to TEPEZZA® (teprotumumab-trbw)..
BU
2021Horizon Therapeutics plc Receives CHMP Positive Opinion for UPLIZNA® (inebilizumab) as ..
BU
2021Horizon Therapeutics plc Announces First Patient Enrolled in Phase 2b Pivotal Trial Eva..
BU
2021Horizon Therapeutics plc to Participate in Upcoming Investor Conferences
BU
2021Horizon Therapeutics plc Receives Top Workplace Awards in Chicago and San Francisco
AQ
2021Horizon Therapeutics - Results from PROTECT Trial Evaluating KRYSTEXXA (pegloticase inj..
AQ
2021Horizon Therapeutics plc Receives Top Workplace Awards in Chicago and San Francisco
BU
2021Results from PROTECT Trial Evaluating KRYSTEXXA® (pegloticase injection) in Kidney Tran..
BU
2021HORIZON THERAPEUTICS : Q3 Earnings Snapshot
AQ
2021HORIZON THERAPEUTICS PUBLIC LTD CO MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL C..
AQ
2021Horizon Therapeutics plc Reports Record Third-Quarter 2021 Financial Results; Increasin..
PU
2021HORIZON THERAPEUTICS PUBLIC LTD CO : Results of Operations and Financial Condition, Change..
AQ
2021Horizon Therapeutics plc Announces Chief Financial Officer Succession Plan
BU
2021Horizon Therapeutics plc Reports Record Third-Quarter 2021 Financial Results; Increasin..
BU
2021New Data Being Presented at American College of Rheumatology Convergence 2021 Highlight..
BU
2021Horizon Therapeutics - MIRROR Randomized Controlled Trial Meets Primary Endpoint and Sh..
AQ
2021HORIZON THERAPEUTICS PUBLIC : MIRROR Randomized Controlled Trial Meets Primary Endpoint an..
BU
2021HORIZON THERAPEUTICS PUBLIC : plc Named to Newsweek's List of the Most Loved Workplaces fo..
AQ
2021HORIZON THERAPEUTICS PLC : Named to Newsweek's List of the Most Loved Workplaces for 2021
BU
2021HORIZON THERAPEUTICS PUBLIC : plc. - Newly Published Data Continue to Support Long-Term Ef..
AQ
2021HORIZON THERAPEUTICS PUBLIC : Newly Published Data Continue to Support Long-Term Efficacy ..
BU
2021HORIZON THERAPEUTICS PUBLIC : plc - New Data Reinforce the Relationship Between B-Cell Dep..
AQ
2021HORIZON THERAPEUTICS PUBLIC : - New TEPEZZA (teprotumumab-trbw) Data to be Presented at th..
AQ
2021HORIZON THERAPEUTICS PUBLIC : New Data Reinforce the Relationship Between B-Cell Depletion..
BU
2021HORIZON THERAPEUTICS PUBLIC : New TEPEZZA® (teprotumumab-trbw) Data to be Presented at the..
BU
2021HORIZON THERAPEUTICS PLC : to Release Third-Quarter 2021 Financial Results and Host Webcas..
BU
2021HORIZON THERAPEUTICS PLC : Named One of the 2021 Top 100 Adoption-Friendly Workplaces by t..
BU
2021HORIZON THERAPEUTICS PUBLIC : plc - New Analysis Published in Multiple Sclerosis Journal A..
AQ
2021HORIZON THERAPEUTICS PUBLIC : plc Announces New UPLIZNA (inebilizumab-cdon) Data in Neurom..
AQ
2021HORIZON THERAPEUTICS PUBLIC : New Analysis Published in Multiple Sclerosis Journal Assesse..
BU
2021HORIZON THERAPEUTICS PLC : Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyeliti..
BU
2021HORIZON THERAPEUTICS PUBLIC LTD CO : Other Events (form 8-K)
AQ
2021HORIZON THERAPEUTICS PLC : Announces New Development Programs at Virtual R&D Day
BU
2021HORIZON THERAPEUTICS PUBLIC :  Horizon Therapeutics plc Announces Agenda for Virtual R&D D..
BU
2021HORIZON THERAPEUTICS PLC : Announces Data Showing UPLIZNA® (inebilizumab-cdon) Also Produc..
BU
2021HORIZON THERAPEUTICS PLC : Announces New Genetic Counselor Curated Algorithms and Next-Gen..
BU
2021HEMOSHEAR THERAPEUTICS : Advancing Several Novel Compounds for Horizon Therapeutics plc Go..
PR
2021HORIZON THERAPEUTICS PLC : Named One of the 2021 Best Workplaces for Women™ by Fortu..
BU
2021HORIZON THERAPEUTICS PUBLIC :  Horizon Therapeutics plc Initiates Randomized Controlled Cl..
BU
2021HORIZON THERAPEUTICS PLC : Named One of PEOPLE's 100 Companies That Care®
BU
2021HORIZON THERAPEUTICS PLC : to Participate in Upcoming Conferences
BU
2021HORIZON THERAPEUTICS : Q2 Earnings Snapshot
AQ
2021HORIZON THERAPEUTICS PUBLIC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION ..
AQ
2021HORIZON THERAPEUTICS PLC : Reports Record Second-Quarter 2021 Financial Results; Increasin..
BU
2021HORIZON THERAPEUTICS PUBLIC : Fortune Names Horizon Therapeutics One of the 2021 Best Work..
BU
2021HORIZON THERAPEUTICS PLC : to Release Second-Quarter 2021 Financial Results and Host Webca..
BU
2021HORIZON THERAPEUTICS PLC : to Host Virtual R&D Day on Sept. 29, 2021
BU
2021HORIZON THERAPEUTICS PLC : Announces First Patient Enrolled in Phase 2 Trial Evaluating HZ..
BU
2021HORIZON THERAPEUTICS PUBLIC : Gail Devers, Three-Time Olympic Gold Medalist, Partners with..
BU
2021HORIZON THERAPEUTICS PUBLIC : IDA Ireland welcomes biotech company Horizon's announcement ..
AQ
2021HORIZON THERAPEUTICS PLC : Announces Multiple Presentations on Neuromyelitis Optica Spectr..
BU
2021HORIZON THERAPEUTICS PLC : Announces Purchase of Manufacturing Facility to Support Growth ..
BU
2021HORIZON THERAPEUTICS PLC : Presents New Data on Robust Pipeline at EULAR European Congress..
BU
2021HORIZON THERAPEUTICS PLC : Initiates ADVANCE Trial Evaluating KRYSTEXXA® (pegloticase inje..
BU
2021HORIZON THERAPEUTICS PLC : to Participate in Upcoming Investor Conferences
BU
2021HORIZON THERAPEUTICS PLC : Highlights Expanding R&D Efforts with Data Presentations at the..
BU
2021HORIZON THERAPEUTICS PLC : Named One of the 2021 Best Workplaces in Chicago™ by Grea..
BU
2021HORIZON THERAPEUTICS PLC : Ranked #1 in Overall Corporate Reputation Among U.S. Patient Gr..
BU
1  2  3  4  5  6  7  8Next
Upcoming event on HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY